New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

11

Global coronavirus cases surpass 60 million infections – Reuters tally

The global tally of confirmed coronavirus cases hit 60 million on Nov. 25, with the pace of new infections accelerating and the United States reporting record numbers of hospitalizations, according to a Reuters tally.

12

Q&A with Kate Cronin

Kate Cronin, Global CEO of Ogilvy Health, shares her views on a variety of healthcare industry topics in a Q&A with Med Ad News.

13

MediciNova’s Ibudilast Reduces Retinal Thinning in MS Trial Subjects

MediciNova received positive Optical Coherence Tomography (OCT) results from the company’s SPRINT-MS Phase IIb trial of MN-166 (ibudilast) in multiple sclerosis subjects.

17

Americans in holiday rush despite highest Covid-19 death toll in 6 months

Record hospitalizations and a surging death toll failed to keep Americans from traveling a day before the Thanksgiving holiday, raising fears that the unchecked spread under way is a prelude to further contagion at Christmastime.

18

‘COVID chat’: Officials urge Americans to stay home over holiday

U.S. health officials and politicians pleaded with Americans to stay at home over the Thanksgiving holiday and abide by constraints placed on social and economic life as record coronavirus caseloads pushed hospitals to their limits.

19

OxyContin maker Purdue Pharma pleads guilty to criminal charges

Purdue Pharma LP pleaded guilty to criminal charges over the handling of the company’s addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker’s role in the U.S. opioid crisis.

20

FDA Approves Flu Treatment for Preventative Use After Exposure

Genentech’s influenza treatment Xofluza (baloxavir marboxil) was granted approval by the U.S. Food and Drug Administration for use in people 12 years and older, making it the first single-dose post-exposure prophylaxis strategy approved by the regulatory agency.